Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Mar 28, 2025; 31(12): 100155
Published online Mar 28, 2025. doi: 10.3748/wjg.v31.i12.100155
Table 1 Population and primary colorectal cancer characteristics (n = 574), n (%)
Parameters
Value
Age, years, mean ± SD70.1 ± 11.36
Sex
    Male347 (60.5)
    Female227 (39.5)
TNM stage
    I125 (21.8)
    II227 (39.5)
    III222 (38.7)
Location
    Right colon153 (26.7)
    Transverse colon35 (6.1)
    Left colon226 (39.4)
    Rectum160 (27.8)
Type of surgery
    Right hemicolectomy165 (28.8)
    Left hemicolectomy/sigmoidectomy204 (35.6)
    Anterior rectal resection140 (24.4)
    Abdomino-peritoneal amputation26 (4.5)
    Other39 (6.8)
Laparoscopic surgery
    Yes133 (23.2)
    No441 (76.8)
Pre-operative complications
    Intestinal perforation22 (3.8)
    Intestinal occlusion48 (8.4)
Postoperative complications
    Suture dehiscence87 (15.2)
    Paralytic ileus28 (4.9)
    Eventration14 (2.4)
    Intra-abdominal infection20 (3.5)
    Other42 (7.3)
Adjuvant chemotherapy
    Yes207 (36.1)
    No367 (63.9)
Neoadjuvant radio-chemotherapy
    Yes71 (12.4)
    No503 (87.6)
Table 2 Analysis of metastases/recurrences detected at follow-up

Liver
Lung
Peritoneal
Anastomotic recurrence
Metachronous CRC
Other
Several locations
Total
CT diagnostic
    CT 1341667331386
    CT 28104415742
    CT 3230212515
    CT 404000228
    CT 501000102
    Total4434101351327146
    Median detection time (months)12 (8.8-15.2)22 (16.3-27.7)13 (6.8-19.2)20 (16.8-23.2)32 (13.2-50.8)26 (16.6-21.4)
Colonoscopy diagnosis
    Colonoscopy 173
    Colonoscopy 240
    Colonoscopy 303
    Total116
    Median detection time (months)22 (18-39.5)
TMs elevation
    Yes3714616721
    No5204955
    % Yes (P = 0.01)88.141.260.064.058.380.8
Table 3 Factors associated with adherence to recommendations for the first follow-up colonoscopy and computed tomography scan, n (%)
The 1st surveillance colonoscopy
P valueMultivariate analysis OR (95%CI)P value
CT 1
P valueMultivariate analysis OR (95%CI)P value
Yes
No
Yes
No
Average age (Number of patients)66.97 (394)76.69 (131)< 0.0010.91 (0.89-0.94)< 0.00168.7 (483)76.6 (56)< 0.0011.06 (1.03-1.10)< 0.001
SexMale245 (76.6)75 (23.4)0.32299 (91.2)29 (8.8)0.14
Female149 (72.7)56 (27.3)184 (87.2)27 (12.8)
TNM stageI-II248 (77.3)71 (22.3)0.051298 (90.0)33 (10.0)0.69
III141 (70.1)60 (29.9)2.47 (1.46-4.18)< 0.001185 (88.9)23 (11.1)
LocationRight colon119 (73.0)44 (27.0)0.47146 (85.9)24 (14.1)0.051
Left colon275 (76.0)87 (24.0)337 (91.3)32 (8.7)0.80 (0.44-0.15)0.46
SurgeryLaparoscopy111 (87.4)16 (12.6)< 0.001 1122 (94.6)7 (5.4)0.031
Laparotomy283 (71.1)115 (28.9)2.59 (1.43-4.78)0.002361 (88.0)49 (12.0)2.03 (0.87-4.71)0.10
Perioperative complicationsYes42 (65.6)22 (34.4)0.06159 (90.8)6 (9.2)0.68
No352 (76.4)109 (23.6)0.99 (0.52-1.88)0.98424 (89.5)50 (10.5)
Postoperative complicationsYes130 (68.8)59 (31.2)0.011173 (89.2)21 (10.8)0.46
No264 (78.6)72 (21.4)0.76 (0.48-1.20)0.24310 (89.9)35 (10.1)
Adjuvant chemotherapyYes173 (84.8)31 (15.2)< 0.0012.11 (1.18-3.78)0.01197 (96.1)8 (3.9)< 0.0012.46 (1.09-5.54)0.03
No221 (68.8)100 (31.2)1286 (85.6)48 (14.4)1
Neoadjuvant radio-chemotherapyYes63 (91.3)6 (8.7)< 0.0012.18 (0.87-5.50)0.0169 (97.2)2 (2.8)0.032.29 (0.51-10.16)0.28
No331 (72.6)125 (27.4)1414 (88.5)54 (11.5)1
Table 4 Risk factors for death at 5-year follow-up, n (%)
All-cause mortality
P value
Multivariate analysis, OR (95%CI)
P value
CCR mortality
P value
Multivariate analysis, OR (95%CI)
P value
Yes
No
Yes
No
Sex
    Male144 (41.5)203 (58.5)0.961 (17.6)286 (82.4)0.7
    Female93 (41.0)134 (59.0)37 (16.3)190 (83.7)
Average age75.366.3< 0.0010.93 (0.91-0.95)< 0.00171.566.3< 0.0010.97 (0.94-0.99)0.05
TNM stage
    I-II125 (35.4)228 (64.6)< 0.0010.38 (0.24-0.61)< 0.00134 (9.6)319 (90.4)< 0.0010.26 (0.15-0.46)< 0.001
    III112 (50.7)109 (49.3)164 (29.0)157 (71.0)1
Location
    Right hemicolon84 (44.7)104 (55.3)0.2529 (15.4)159 (84.6)0.46
    Left hemicolon153 (39.6)233 (60.4)69 (17.9)317 (82.1)
Surgery
    Laparoscopy42 (31.6)91 (68.4)0.010.72 (0.44-1.17)0.1917 (12.8)116 (87.2)0.130.68 (0.36-1.27)0.22
    Laparotomy195 (44.2)246 (55.8)181 (18.4)360 (81.6)1
Perioperative complications
    Yes36 (51.4)34 (48.6)0.071.14 (0.62-2.09)0.6820 (28.6)50 (71.4)0.011.72 (0.91-3.27)0.1
    No201 (39.9)303 (60.1)178 (15.5)426 (84.5)1
Postoperative complications
    Yes113 (51.6)106 (48.4)< 0.0011.41 (0.93-2.14)0.142 (19.2)117 (80.8)0.291.25 (0.72-2.04)0.37
    No124 (34.9)231 (65.1)156 (15.8)299 (84.2)1
Adjuvant chemotherapy
    Yes71 (34.3)136 (65.7)0.011.04 (0.64-1.74)0.8450 (26.9)136 (73.1)0.061.60 (0.95-2.72)0.08
    No166 (45.2)201 (54.8)148 (19.3)201 (80.7)1
Neoadjuvant chemo-radiotherapy
    Yes21 (29.6)50 (70.4)0.031.14 (0.61-2.31)0.6912 (19.4)50 (80.6)0.518
    No216 (42.9)287 (57.1)186 (23.1)287 (76.9)
Adherence to follow-up recommendations
    Yes62 (21.6)225 (78.4)< 0.0010.30 (0.20-0.46)< 0.00132 (12.5)225 (87.5)< 0.0010.35 (0.21-0.59)< 0.001
    No141 (55.7)112 (44.3)165 (36.7)112 (63.3)1